Alexey V. Sulimov

Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Consensus of the International Interdisciplinary Expert Council on the treatment of comorbidities in pediatric ADHD

Consensus of the International Interdisciplinary Expert Council on the treatment of comorbidities in pediatric ADHD

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: May 14, 2026

Search for acetylcholinesterase inhibitors by computerized screening of approved drug compounds.

Search for acetylcholinesterase inhibitors by computerized screening of approved drug compounds.

Journal: SAR and QSAR in environmental research

Published: December 03, 2025

Molecular Docking of Chiral Drug Enantiomers With Different Bioactivities.

Molecular Docking of Chiral Drug Enantiomers With Different Bioactivities.

Journal: Chirality

Published: March 19, 2024

Docking and other computing tools in drug design against SARS-CoV-2.

Docking and other computing tools in drug design against SARS-CoV-2.

Journal: SAR and QSAR in environmental research

Published: February 14, 2024

Design, Synthesis, and Evaluation of New Hybrid Derivatives of 5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-2(1H)-one as Potential Dual Inhibitors of Blood Coagulation Factors Xa and XIa.

Design, Synthesis, and Evaluation of New Hybrid Derivatives of 5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-2(1H)-one as Potential Dual Inhibitors of Blood Coagulation Factors Xa and XIa.

Journal: Molecules (Basel, Switzerland)

Published: October 30, 2023

New Hybrid Tetrahydropyrrolo[3,2,1-ij]quinolin-1-ylidene-2-thioxothiazolidin-4-ones as New Inhibitors of Factor Xa and Factor XIa: Design, Synthesis, and In Silico and Experimental Evaluation.

New Hybrid Tetrahydropyrrolo[3,2,1-ij]quinolin-1-ylidene-2-thioxothiazolidin-4-ones as New Inhibitors of Factor Xa and Factor XIa: Design, Synthesis, and In Silico and Experimental Evaluation.

Journal: Molecules (Basel, Switzerland)

Published: March 21, 2023

New Chemicals Suppressing SARS-CoV-2 Replication in Cell Culture.

New Chemicals Suppressing SARS-CoV-2 Replication in Cell Culture.

Journal: Molecules (Basel, Switzerland)

Published: August 16, 2022

Experimentally Validated Novel Factor XIIa Inhibitors Identified by Docking and Quantum Chemical Post-processing.

Experimentally Validated Novel Factor XIIa Inhibitors Identified by Docking and Quantum Chemical Post-processing.

Journal: Molecular informatics

Published: August 14, 2022

Novel Inhibitors of 2'-O-Methyltransferase of the SARS-CoV-2 Coronavirus.

Novel Inhibitors of 2'-O-Methyltransferase of the SARS-CoV-2 Coronavirus.

Journal: Molecules (Basel, Switzerland)

Published: March 25, 2022

New Blood Coagulation Factor XIIa Inhibitors: Molecular Modeling, Synthesis, and Experimental Confirmation.

New Blood Coagulation Factor XIIa Inhibitors: Molecular Modeling, Synthesis, and Experimental Confirmation.

Journal: Molecules (Basel, Switzerland)

Published: January 10, 2022

Quantum-Chemical Quasi-Docking for Molecular Dynamics Calculations.

Quantum-Chemical Quasi-Docking for Molecular Dynamics Calculations.

Journal: Nanomaterials (Basel, Switzerland)

Published: December 03, 2021

Development of antiviral drugs based on inhibitors of the SARS-COV-2 main protease

Development of antiviral drugs based on inhibitors of the SARS-COV-2 main protease

Journal: Biomeditsinskaia khimiia

Published: June 18, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026